Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICCO-monitored comparison of iodixanol versus iopromide in cardio-renal syndrome patients undergoing PCI
ChiCTR-TRC-13003477Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of iodixanol and iopromide in coronary arteriosclerosis, heart failure (HF) and chronic kidney disease (CKD) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Extravascular Lung Water Index. Started Jul 2013; status: completed.
02
Drugs
iodixanoliopromide
03
Conditions
coronary arteriosclerosisheart failure (HF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR-TRC-13003477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003477.